文献速递区域麻醉与超声术前评估与围术期医学

双侧竖脊肌平面阻滞后利多卡因的药代动力学

Pharmacokinetics of lidocaine after bilateral ESP block.
PubMed 文献 · Reg Anesth Pain Med · 2020-08-31

该病例系列纳入10例多节段腰椎手术患者,行双侧竖脊肌平面(ESP)阻滞,按理想体重给予利多卡因3.5 mg/kg,于5、15、30分钟及1、2、3小时测定血药浓度。结果显示所有患者Tmax均为5分钟,Cmax为1.2–3.8 mg/L(均值2.59 mg/L),AUC0-3平均占总暴露76%,提示吸收迅速且生物利用度接近完全;峰浓度未超过公认毒性上限,消除半衰期轻度延长,可能与部分患者高龄相关。

要点

  • 双侧ESP阻滞后利多卡因吸收迅速,所有患者Tmax均为5分钟。
  • Cmax为1.2–3.8 mg/L(均值2.59 mg/L),未超过公认毒性上限。
  • AUC0-3平均占76%,提示生物利用度接近完全,高龄者消除半衰期轻度延长。

核心结论

  • 双侧ESP阻滞后利多卡因药代动力学可用二室模型描述,吸收迅速且广泛。
  • 峰浓度未超过公认毒性上限,消除半衰期轻度延长,可能与部分患者高龄有关。

研究设计与样本

  • 病例系列,纳入10例接受多节段腰椎手术并行双侧ESP阻滞的患者。
  • ESP阻滞按理想体重给予利多卡因3.5 mg/kg。
  • 于给药后5、15、30分钟及1、2、3小时测定利多卡因血药浓度。

主要发现

  • 所有患者Tmax均为5分钟。
  • Cmax范围为1.2–3.8 mg/L,均值为2.59 mg/L。
  • AUC0-3平均为76%,提示生物利用度接近完全。
  • 年龄与利多卡因消除半衰期呈负相关。

临床怎么用

  • 双侧ESP阻滞使用利多卡因3.5 mg/kg(理想体重)时,本组患者峰浓度未超过公认毒性上限。
  • 吸收迅速,需关注给药后早期血药浓度变化。

局限性

  • 样本量小,仅10例。
  • 原文未报告更多局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Erector spinae plane (ESP) block is an emerging interfascial block with a wide range of indications for perioperative analgesia and chronic pain treatment. Recent studies have focused their attention on mechanisms of action of ESP block. However, the pharmacokinetics of drugs injected in ESP is, as of now, uninvestigated. The aim of this brief report is to investigate the pharmacokinetics of lidocaine in a series of 10 patients. METHODS: We are reporting a case series of 10 patients undergoing bilateral ESP block for multilevel lumbar spine surgery.ESP was performed with 3.5 mg/kg of lidocaine based on ideal body weight. Lidocaine concentration was dosed at 5, 15, 30 min and at 1, 2 and 3 hours. RESULTS: Tmax was 5 min for all the patients. Cmax ranged from 1.2 to 3.8 mg/L (mean: 2.59 mg/L). AUC0-3 was high (76%, on average) suggesting an almost complete bioavailability. Age had a negative correlation with T½ of lidocaine. CONCLUSIONS: Lidocaine pharmacokinetic after ESP block is well-described by a two-compartment model with a rapid and extensive rate of absorption. Nevertheless, its peak concentrations never exceeded the accepted toxicity limit. Elimination half-life was slightly prolonged, probably due to the advanced age of some patients.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. De Cassai A, Bonanno C, Padrini R, et al. Pharmacokinetics of lidocaine after bilateral ESP block. Reg Anesth Pain Med. 2020. PMID: 32868484. doi:10.1136/rapm-2020-101718

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。